ArticleOSA continuum2020
Holographic waveguide based optometer for the quantitative monitoring of ocular refractive error.
Article in OSA continuum, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Oculomotor disorders are known to have profound impacts on a patients' quality of life. However, current clinical practice lacks the capability to provide simultaneous assessment of three tightly coupled oculomotor control components, i.e. eye movement, lens accommodation, and pupil response. In this study, a holographic waveguide (HW) based benchtop optometer was constructed and evaluated with a model eye. Experimental result and quantitative analysis indicate that a HW can convey high quality retinal images to a camera at an illumination level safe for human subjects and support high accuracy measurements of ocular refractive error over a wide range. Further development of a HW-based system promises a wearable, see-through device for comprehensive assessment of oculomotor control components while the subject is engaged in normal daily activities and thus enable advanced research and clinical management of oculomotor disorders.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.